AzTrials
AzTrials

BreastfeedingNCT04835051

Alive & Thrive Nigeria Breastfeeding Promotion in Urban Private Facilities Study

A study testing Breastfeeding promotion in people with Breastfeeding, run by RTI International at 20 sites in Nigeria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to evaluate the effect of a breastfeeding promotion intervention on breastfeeding intentions, early initiation of breastfeeding, and exclusive breastfeeding among clients in private health facilities in Lagos, Nigeria. Read more about this study

Who is it for?
Ages 15 to 49 yearsHealthy volunteers can take part
Conditions the study is for
Breastfeeding
What is being tested?
Breastfeeding promotion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,220 participants
Where
20 sitesNigeria
Study dates
5 Aug 2019to 17 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 49 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Women ≥18 years old, third trimester
  • Current Client of a private health facility
  • Infant alive at 6 and 24 weeks postpartum

Who cannot join

  • Infant died
  • Infant unable to breastfeed

Trial locations and contacts

20 sites in 1 country.

20 sites in 1 country

Nigeria20 sites
  • Albina Majeed Clinic

    Lagos

  • Ayodele Medical Centre

    Lagos

  • Crystal Specialist

    Lagos

  • Edmac Medical Centre

    Lagos

  • Eko Hospital

    Lagos

  • El-Dunamis Medical Centre

    Lagos

  • Faith City Hospital

    Lagos

  • Fuja Medical Centre

    Lagos

  • Ilogbo Central Hospital

    Lagos

  • Isalu Hospital

    Lagos

  • Matador Hospital

    Lagos

  • Mobonike Hospital

    Lagos

  • Modupeoluwa Mat.Home

    Lagos

  • Promise Medical Centre

    Lagos

  • R-Jolard Hospital

    Lagos

  • Rccg Ebute Metta

    Lagos

  • Rccg Oke Suna

    Lagos

  • Redeemed Maternity Amuwo

    Lagos

  • Regina Mundi Catholic Hospital

    Lagos

  • Uwemdimo Hospital

    Lagos

Other trials in Nigeria

About this study

Official title: Implementation Research on an Urban Private Sector Model of IYCF Counseling in Private Health Facilities in Lagos State

The purpose of this study was to evaluate the effect of a breastfeeding promotion intervention on breastfeeding intentions, early initiation of breastfeeding, and exclusive breastfeeding among clients in private health facilities in Lagos, Nigeria.

Read the detailed description

This was a longitudinal cohort study designed to evaluate and measure the implementation processes of a breastfeeding counseling and support intervention offered to pregnant and postpartum women in private health facilities in Lagos State, Nigeria. This study was conducted as part of the Alive \& Thrive Nigeria program, implemented by FHI 360 and partners. RTI led the design, implementation, and analysis for the study, with Datametrics Associates Ltd. serving as the data collection partner in Nigeria. The study took place in 20 private health facilities. Ten facilities were assigned to intervention and 10 to comparison based on their location within the existing intervention and comparison local government areas (LGAs) for our overall impact evaluation of the Alive \& Thrive program in Nigeria (NCT02975063). To be included in the study, facilities had to provide maternity and pediatric services, such as antenatal care, postnatal care, and immunizations, and be registered with the Association of General and Private Medical Practitioners of Nigeria and the Health Facility Monitoring and Accreditation Agency. To ensure that the investigators would achieve their sample size, selected facilities with a monthly average of ≥40 antenatal clients and ≥20 deliveries over 3 months. All eligible women attending antenatal care on the days of data collection were invited to participate until the target enrollment at each facility was achieved. The investigators collected survey data from a cohort of 1,200 women (600 per study arm) during the third trimester of pregnancy and when their child was 6 weeks and 24 weeks. The purpose of the surveys were to obtain data on the women's breastfeeding intentions (third trimester) and practices (6 weeks and 24 weeks), their breastfeeding knowledge and attitudes, and their exposure to the intervention. To measure implementation outcomes, the investigators conducted 180 observations of client-provider interactions among a subset of women enrolled in the study and then completed a short exit interview with the women immediately after their facility visit. In addition, the investigators conducted qualitative interviews with 20 health providers and facility managers/owners in the intervention facilities at the end of the intervention to learn about the facilitators and barriers to implementation.

Conditions
Breastfeeding
Being tested
Breastfeeding promotion
Keywords
Exclusive breastfeeding, Early initiation of breastfeeding
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breastfeeding promotionBehavioural

    The intervention included training of health workers in private health facilities to provide in-person breastfeeding counseling to pregnant women and women with a child <6 months during clinic visits. The health workers also offered a mobile phone support component for appointment reminders, breastfeeding SMS and WhatsApp messages, WhatsApp breastfeeding support groups, informational materials (posters and foldable pocket-sized cards), and family engagement activities. Breastfeeding-related mass media through television and radio spots was available state-wide, including to women in intervention and comparison facilities.

Study groups in NCT04835051
Study groupRoleWhat they receive
Breastfeeding promotionOtherThe breastfeeding promotion intervention included training for health workers, interpersonal communication (in person and digital) between providers and pregnant/breastfeeding women, and mass media.
Receives: Behavioral: Breastfeeding promotion
ComparisonNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exclusive breastfeeding

    The proportion of infants exclusively breastfed on the previous day

    Measured: 6 weeks

  2. Exclusive breastfeeding

    The proportion of infants exclusively breastfed on the previous day

    Measured: 24 weeks

Secondary outcomes (1)
  1. Early initiation of breastfeeding

    The proportion of infants who started breastfeeding within 1 hour of birth

    Measured: At birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2021
  2. Study start5 Aug 2019
  3. Primary completion17 Jul 2020
  4. Study completion17 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04835051
Sponsor's protocol ID
20576
Status last verified
Jan 2021
First submitted
23 Feb 2021
Last updated
8 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared publicly through Harvard Dataverse.

Publications

  • Flax VL, Ipadeola A, Schnefke CH, Ralph-Opara U, Adeola O, Edwards S, Bose S, Brower AO. Breastfeeding Interpersonal Communication, Mobile Phone Support, and Mass Media Messaging Increase Exclusive Breastfeeding at 6 and 24 Weeks Among Clients of Private Health Facilities in Lagos, Nigeria. J Nutr. 2022 May 5;152(5):1316-1326. doi: 10.1093/jn/nxab450.

    PubMed 35015869

Questions about this trial

What is this clinical trial studying?

A study testing Breastfeeding promotion in people with Breastfeeding, run by RTI International at 20 sites in Nigeria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 20 sites in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exclusive breastfeeding (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04835051, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in